Number of the records: 1
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro
- 1.
SYSNO ASEP 0446880 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro Author(s) Řezníčková, Eva (UEB-Q) RID, ORCID
Popa, Alexandr (UEB-Q)
Gucký, Tomáš (UEB-Q) ORCID
Zatloukal, Marek (UEB-Q) ORCID
Havlíček, Libor (UEB-Q) RID, ORCID
Bazgier, Václav (UEB-Q) ORCID, RID
Berka, K. (CZ)
Jorda, Radek (UEB-Q) ORCID, RID
Popa, Igor (UEB-Q)
Nasereddin, A. (IL)
Jaffe, Ch. L. (IL)
Kryštof, Vladimír (UEB-Q) RID, ORCID
Strnad, Miroslav (UEB-Q) RID, ORCIDSource Title Bioorganic and Medicinal Chemistry Letters. - : Elsevier - ISSN 0960-894X
Roč. 25, č. 11 (2015), s. 2298-2301Number of pages 4 s. Language eng - English Country GB - United Kingdom Keywords Purine ; Cyclin-dependent kinase ; Leishmania Subject RIV EB - Genetics ; Molecular Biology R&D Projects LO1204 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Institutional support UEB-Q - RVO:61389030 UT WOS 000354115400007 DOI 10.1016/j.bmcl.2015.04.030 Annotation Here we describe the leishmanicidal activities of a library of 2,6,9-trisubstituted purines that were screened for interaction with Cdc2-related protein kinase 3 (CRK3) and subsequently for activity against parasitic Leishmania species. The most active compound inhibited recombinant CRK3 with an IC50 value of 162 nM and was active against Leishmania major and Leishmania donovani at low micromolar concentrations in vitro. Its mode of binding to CRK3 was investigated by molecular docking using a homology model. Workplace Institute of Experimental Botany Contact David Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469 Year of Publishing 2016
Number of the records: 1